Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Jianbang Pharmaceutical Technology Development is a pharmaceutical enterprise based in Changchun, China, that focuses on the research, development, and technology transfer of chemical drugs and traditional Chinese medicine. The company operates primarily as an R&D and technology service entity, supporting the development of generic medications and over-the-counter (OTC) products. Its portfolio, often commercialized through its manufacturing affiliates, includes a variety of oral solid dosage forms such as tablets and capsules for respiratory, cardiovascular, and metabolic health. The firm is active in the Chinese domestic market, emphasizing pharmaceutical formulation modernization and consistency evaluation for generic drugs. It plays a role in the regional life sciences ecosystem of Jilin Province by bridging drug discovery with manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Jianbang Pharmaceutical Technology Development.